Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

DuPont de Nemours, Inc. (DD)

CIK 0001666700 4 material events

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 0 buyers bought $0 0 sellers sold $0
Open-market · last 90 days: 0 buyers bought $0 0 sellers sold $0
InsiderRoleDateTransactionSharesValue
CUTLER ALEXANDER M Director 2026-08-28 Grant/award 365 $50K
Lowery Frederick M. Director 2026-08-28 Grant/award 283 $39K
Macpherson Donald G Director 2026-08-28 Grant/award 237 $32K
BREEN EDWARD D Director 2026-08-17 Gift 34485 $0
Barber Madeleine G VP Chief Accounting Officer 2026-08-06 Tax withholding 101 $15K
Ferreira Beth President, Diversified Indstrl 2026-08-06 Tax withholding 374 $55K
Koch Lori CEO, Director 2026-06-02 Open-market sell 261 $13K
Franzen Antonella B SVP & CFO 2026-05-31 Tax withholding 1558 $75K
Koch Lori CEO, Director 2026-05-31 Tax withholding 4673 $224K
CUTLER ALEXANDER M Director 2026-05-29 Grant/award 1033 $50K
Lowery Frederick M. Director 2026-05-29 Grant/award 800 $39K
Macpherson Donald G Director 2026-05-29 Grant/award 671 $32K
BREEN EDWARD D Director 2026-05-21 Grant/award 4030 $0
Brady Amy G. Director 2026-05-21 Grant/award 4030 $0
CHANDY RUBY R Director 2026-05-21 Grant/award 4030 $0
CUTLER ALEXANDER M Director 2026-05-21 Grant/award 4030 $0
LICO JAMES A Director 2026-05-21 Grant/award 4030 $0
Lowery Frederick M. Director 2026-05-21 Grant/award 4030 $0
Macpherson Donald G Director 2026-05-21 Grant/award 4030 $0
McMaken Kurt B Director 2026-05-21 Grant/award 4030 $0
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Risk Radar (year-over-year Risk Factors)

← All Risk Radar

Fiscal period ending 2025-12-31 versus 2024-12-31view filing on EDGAR →

DuPont's risk profile is reshaping around the Qnity separation and Aramids divestiture, introducing fresh covenant constraints, indemnification exposure, and PFAS liability escalation that outweigh the relief from abandoning the Electronics Separation. The new $1.4B Minimum EBITDA covenant materially limits portfolio flexibility, while a SAMR antitrust investigation into Tyvek and sharpened environmental remediation uncertainty add regulatory and contingent liability weight. Partial offsets — reduced international sales concentration and contractual tax-liability sharing with Qnity — are real but do not neutralize the net worsening on the legal and strategic axes.

6 company-specific · 4 eased/removed

Company-specific changes

New

New disclosure of material divestiture risk. Aramids sale expected Q1 2026 with regulatory, timing, and operational separation uncertainties that could impact value and results.

The timing and outcome of the Aramids Divestiture is subject to risk and uncertainties. The Aramids Divestiture is expected to close around the end of the first quarter 2026, subject to customary…

New

New disclosure of trade tensions, tariffs, export controls, and specific SAMR antitrust investigation into Tyvek business. China represents ~10% of sales; material geopolitical and regulatory risk.

Risks Related to Regulatory Changes and Compliance Risks related to recent trade disputes, responsive actions, investigations by foreign governments, regulations and policies could have an adverse…

Revised

New separation (Qnity) introduces fresh indemnification obligations and legacy liabilities exposure, expanding DuPont's contingent liability footprint beyond prior Dow/Corteva separations.

In connection with the Qnity Distribution, certain liabilities are allocated to or retained by DuPont through assumption or indemnification of Qnity. If DuPont is required to make payments pursuant…

Revised

New disclosure of Qnity Distribution and reset Minimum EBITDA covenant at $1.4B materially constrains DuPont's portfolio flexibility and divestiture capacity post-separation.

Failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions could adversely impact the Company’s business, results of operations, financial condition and cash…

Revised

Environmental remediation cost estimation now explicitly acknowledges "considerable uncertainty" and potential for "materially higher" liabilities than accrued, escalating disclosure of PFAS/Stray Liability risk.

In connection with the DWDP Distributions, certain liabilities are allocated to or retained by DuPont through assumption or indemnification of Dow and/or Corteva, as applicable. If DuPont is required…

Revised

New disclosure of Qnity tax liability allocation under Electronics Tax Matters Agreement expands Company's potential indemnification exposure beyond prior DWDP structure.

If the Corteva Distribution or the Dow Distribution, in each case, together with certain related transactions, were to fail to qualify for non-recognition treatment for U.S. federal income tax…

Eased / removed

Removed

Removal of major strategic separation risk. Intended Electronics Separation no longer disclosed as material risk, indicating transaction abandoned or substantially de-risked.

Risks related to the Intended Electronics Separation DuPont may be unable to achieve all the benefits that it expects to achieve from the Intended Electronics Separation, if the Intended Electronics…

Removed

Removal of Electronics Separation risk eliminates material uncertainty around $7.2B debt refinancing, credit rating downgrades, and liquidity constraints tied to that transaction.

The Intended Electronics Separation may adversely impact DuPont’s ability to access the capital markets and its cost of capital. The Intended Electronics Separation may have the effect of, among…

Revised

International sales declined from 67% to 53% of net sales, reducing exposure to geopolitical and FX risks. Removal of Asia Pacific/China emphasis and South Korean won exposure also signals reduced concentration risk.

A significant percentage of the Company’s net sales are generated from the Company’s international operations and are subject to economic, geo-political, foreign exchange and other risks. DuPont…

Revised

Addition of Electronics Tax Matters Agreement allocation mechanism with Qnity reduces DuPont's direct tax liability exposure by contractually shifting portions to Qnity based on Applicable Percentage.

DuPont is subject to continuing contingent tax-related liabilities of Dow and Corteva following the DWDP Distributions. After the DWDP Distributions, there are several significant areas where the…

Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.

Material Litigation

8-K filed 2026-09-10 confidence 92% Item 1.01

DuPont entered into a settlement agreement with the State of North Carolina and 11 local entities to resolve PFAS-related litigation and claims, with DuPont's pre-tax share valued at approximately $126 million (net present value ~$125 million) in aggregate cash payments over 15 years. The settlement resolves multiple claims relating to PFAS contamination from the Fayetteville Works facility and AFFF use.

View raw filing on EDGAR →

Earnings release

8-K filed 2026-08-04 confidence 98% Item 2.02

DuPont issued a press release on August 4, 2026, announcing second quarter 2026 financial results, including net sales of $1.8 billion (up 4%), GAAP income from continuing operations of $191 million, adjusted EPS of $1.88, and raised full-year 2026 guidance. The press release is attached as Exhibit 99.1 and disclosed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases.

View raw filing on EDGAR →

Shareholder vote

8-K filed 2026-05-26 confidence 98% Item 5.07

DuPont held its Annual Meeting of Stockholders on May 21, 2026, with shareholders voting on four agenda items: election of 10 directors, advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as auditor, and approval of a reverse stock split amendment. The reverse stock split approval is particularly material as it represents a significant corporate action requiring stockholder authorization.

View raw filing on EDGAR →

Other material

8-K filed 2026-05-26 confidence 75% Item 7.01

The Board of Directors approved a 1-for-3 reverse stock split effective June 24, 2026, which directly affects share count and per-share metrics for all shareholders.

View raw filing on EDGAR →